SG11202003044SA - Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof - Google Patents

Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof

Info

Publication number
SG11202003044SA
SG11202003044SA SG11202003044SA SG11202003044SA SG11202003044SA SG 11202003044S A SG11202003044S A SG 11202003044SA SG 11202003044S A SG11202003044S A SG 11202003044SA SG 11202003044S A SG11202003044S A SG 11202003044SA SG 11202003044S A SG11202003044S A SG 11202003044SA
Authority
SG
Singapore
Prior art keywords
light chain
human animals
lambda light
engineered immunoglobulin
immunoglobulin lambda
Prior art date
Application number
SG11202003044SA
Inventor
Andrew J Murphy
Lynn Macdonald
Chunguang Guo
John Mcwhirter
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11202003044SA publication Critical patent/SG11202003044SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1264—DNA nucleotidylexotransferase (2.7.7.31), i.e. terminal nucleotidyl transferase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11202003044SA 2017-12-05 2018-12-04 Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof SG11202003044SA (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762594946P 2017-12-05 2017-12-05
US201762594944P 2017-12-05 2017-12-05
US201762609241P 2017-12-21 2017-12-21
US201762609251P 2017-12-21 2017-12-21
PCT/US2018/063841 WO2019113065A1 (en) 2017-12-05 2018-12-04 Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof

Publications (1)

Publication Number Publication Date
SG11202003044SA true SG11202003044SA (en) 2020-04-29

Family

ID=64734263

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003044SA SG11202003044SA (en) 2017-12-05 2018-12-04 Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof

Country Status (22)

Country Link
US (3) US20210345591A1 (en)
EP (2) EP3720279B1 (en)
JP (2) JP7430636B2 (en)
KR (1) KR20200093570A (en)
CN (2) CN116058333A (en)
AU (1) AU2018381316A1 (en)
BR (1) BR112020011184A2 (en)
CA (1) CA3084049A1 (en)
DK (1) DK3720279T3 (en)
ES (1) ES2928995T3 (en)
HR (1) HRP20221459T1 (en)
HU (1) HUE060608T2 (en)
IL (1) IL274797A (en)
LT (1) LT3720279T (en)
MX (1) MX2020005830A (en)
PL (1) PL3720279T3 (en)
PT (1) PT3720279T (en)
RS (1) RS63772B1 (en)
SG (1) SG11202003044SA (en)
SI (1) SI3720279T1 (en)
TW (1) TWI827567B (en)
WO (1) WO2019113065A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017095939A1 (en) 2015-12-03 2017-06-08 Trianni, Inc. Enhanced immunoglobulin diversity
CA3084049A1 (en) 2017-12-05 2019-06-13 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof
CN112312766A (en) 2018-06-14 2021-02-02 瑞泽恩制药公司 Non-human animals having DH-DH rearrangement capability in immunoglobulin heavy chain coding sequences
CA3127153A1 (en) 2019-02-22 2020-08-27 Regeneron Pharmaceuticals, Inc. Rodents having genetically modified sodium channels and methods of use thereof
KR20220025839A (en) * 2019-07-01 2022-03-03 트리아니, 인코포레이티드 Transgenic mammals and methods of use thereof
WO2022056276A1 (en) 2020-09-11 2022-03-17 Regeneron Pharmaceuticals, Inc. Identification and production of antigen-specific antibodies
KR20230147048A (en) 2020-12-16 2023-10-20 리제너론 파마슈티칼스 인코포레이티드 Mice expressing humanized Fc alpha receptors
MX2023007401A (en) 2020-12-23 2023-07-06 Regeneron Pharma Nucleic acids encoding anchor modified antibodies and uses thereof.
TW202242114A (en) 2020-12-23 2022-11-01 美商再生元醫藥公司 Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same
CN114763558B (en) * 2021-01-14 2024-02-20 上海泰槿生物技术有限公司 Recombinant genome, non-human mammalian cell, and methods of producing and using the same

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
CA2078539C (en) * 1991-09-18 2005-08-02 Kenya Shitara Process for producing humanized chimera antibody
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
KR20080059467A (en) * 1996-12-03 2008-06-27 아브게닉스, 인크. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
GB9823930D0 (en) 1998-11-03 1998-12-30 Babraham Inst Murine expression of human ig\ locus
IL154751A0 (en) * 2000-08-03 2003-10-31 Humanized antibodies, recombination vectors, transgenic vectors and methods for the preparation of humanized antibodies from transgenic animals
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
JP2005510253A (en) 2001-11-30 2005-04-21 アブジェニックス インコーポレイテッド Transgenic animal carrying human Igλ light chain gene
US7582298B2 (en) 2006-06-02 2009-09-01 Regeneron Pharmaceuticals, Inc. High affinity antibodies to human IL-6 receptor
WO2009034158A2 (en) * 2007-09-12 2009-03-19 Probiodrug Ag Transgenic mice
RU2731084C2 (en) * 2008-06-27 2020-08-28 Мерюс Н.В. Producing non-human mammalian antibodies
EP3889265A1 (en) 2008-09-30 2021-10-06 Ablexis, LLC Transgenic mice for the production of chimeric antibodies
JP5944312B2 (en) 2009-07-08 2016-07-05 カイマブ・リミテッド Animal models and therapeutic molecules
US9445581B2 (en) * 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
NZ627119A (en) 2010-06-22 2015-05-29 Regeneron Pharma Hybrid light chain mice
ME03732B (en) 2011-02-25 2021-01-20 Regeneron Pharma ADAM6 mice
RU2743589C2 (en) 2011-10-17 2021-02-20 Регенерон Фармасьютикалс, Инк. Mice with limited heavy chain immunoglobulin
US9253965B2 (en) * 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
KR102038974B1 (en) * 2011-12-20 2019-10-31 리제너론 파마슈티칼스 인코포레이티드 Humanized light chain mice
KR20190006029A (en) * 2012-02-01 2019-01-16 리제너론 파마슈티칼스 인코포레이티드 Humanized rodents that express heavy chains containing vl domains
KR102126217B1 (en) * 2012-06-12 2020-06-24 리제너론 파마슈티칼스 인코포레이티드 Humanized non-human animals with restricted immunoglobulin heavy chain loci
SG11201505968WA (en) 2013-02-20 2015-08-28 Regeneron Pharma Genetic modification of rats
SG11201508028QA (en) 2013-04-16 2015-10-29 Regeneron Pharma Targeted modification of rat genome
JP7133902B2 (en) * 2013-10-01 2022-09-09 カイマブ・リミテッド Animal models and therapeutic molecules
SG10201803444YA (en) 2014-06-23 2018-06-28 Regeneron Pharma Nuclease-mediated dna assembly
CN113444747A (en) 2014-11-21 2021-09-28 瑞泽恩制药公司 Methods and compositions for targeted genetic modification using paired guide RNAs
CN107208113A (en) 2014-12-19 2017-09-26 瑞泽恩制药公司 Method and composition for carrying out targeting genetic modification by the multiple targeting of single step
SI3462853T1 (en) 2016-06-03 2023-05-31 Regeneron Pharmaceuticals, Inc. Rodents expressing exogenous terminal deoxynucleotidyltransferase
CA3084049A1 (en) 2017-12-05 2019-06-13 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof

Also Published As

Publication number Publication date
LT3720279T (en) 2022-10-25
WO2019113065A1 (en) 2019-06-13
PT3720279T (en) 2022-10-06
EP3720279A1 (en) 2020-10-14
MX2020005830A (en) 2020-08-20
RU2020118699A (en) 2022-01-10
HRP20221459T1 (en) 2023-01-20
CA3084049A1 (en) 2019-06-13
RU2020118699A3 (en) 2022-04-07
JP2021505141A (en) 2021-02-18
KR20200093570A (en) 2020-08-05
US20210345591A1 (en) 2021-11-11
CN116058333A (en) 2023-05-05
JP2024036440A (en) 2024-03-15
HUE060608T2 (en) 2023-03-28
AU2018381316A1 (en) 2020-04-23
TWI827567B (en) 2024-01-01
BR112020011184A2 (en) 2020-11-17
US20190223418A1 (en) 2019-07-25
US20210292439A1 (en) 2021-09-23
EP3720279B1 (en) 2022-09-21
SI3720279T1 (en) 2022-11-30
CN111432635A (en) 2020-07-17
DK3720279T3 (en) 2022-10-24
JP7430636B2 (en) 2024-02-13
CN111432635B (en) 2022-10-21
PL3720279T3 (en) 2023-01-16
IL274797A (en) 2020-07-30
TW201938019A (en) 2019-10-01
ES2928995T3 (en) 2022-11-24
US11051498B2 (en) 2021-07-06
RS63772B1 (en) 2022-12-30
EP4140297A1 (en) 2023-03-01

Similar Documents

Publication Publication Date Title
IL274797A (en) Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof
IL266282A (en) Non-human animals having an engineered immunoglobulin lambda light chain locus
IL260937A (en) Fabs-in-tandem immunoglobulin and uses thereof
IL264358A (en) Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
HK1256173A1 (en) Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof
HK1250038A1 (en) Non-human animals that select for light chain variable regions that bind antigen
IL273749A (en) Vegfr-antibody light chain fusion protein
IL268049A (en) Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci
ZA201804136B (en) Repellent and attractant composition for dichromatic animals
ES1214659Y (en) SEAT BELT CLOSURE WITH LIGHTING
UA37426S (en) POLYESTER CHAIN
UA37431S (en) POLYESTER CHAIN
UA37422S (en) POLYESTER CHAIN
ES1155360Y (en) Training belt and canine control